Skip to main content

Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL Title Category Date Recent Activity
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/34th-international-conference-pharmacoepidemiology-and 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Sentinel Initiative Events
34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Sentinel Initiative Events
https://www.sentinelinitiative.org/methods-data-tools/methods/near-real-time-monitoring-critical-drugs-care-patients-covid-19 Near Real-Time Monitoring of Critical Drugs for the Care of Patients with COVID-19 Methods, Data, & Tools
Near Real-Time Monitoring of Critical Drugs for the Care of Patients with COVID-19
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/36th-international-conference-pharmacoepidemiology-and 36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Publications and Presentations
36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/covid-19-ready-public-health-surveillance-system-food-and A COVID‐19‐Ready Public Health Surveillance System: The Food and Drug Administration's Sentinel System Publications and Presentations
A COVID‐19‐Ready Public Health Surveillance System: The Food and Drug Administration's Sentinel System
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/strategies-use-real-world-data-conduct-covid-19-related Strategies for the Use of Real-World Data to Conduct COVID-19-Related Pharmacoepidemiology Publications and Presentations
Strategies for the Use of Real-World Data to Conduct COVID-19-Related Pharmacoepidemiology
Publications and Presentations
https://www.sentinelinitiative.org/methods-data-tools/methods/making-medicaid-data-more-accessible-through-common-data-models-and-fhir Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs Methods, Data, & Tools
Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/n-nitrosodimethylamine-ndma-contaminated-and-non-ndma N‐nitrosodimethylamine (NDMA)‐Contaminated and Non‐NDMA‐Contaminated Valsartan Use: A Descriptive Analysis Analyses
N‐nitrosodimethylamine (NDMA)‐Contaminated and Non‐NDMA‐Contaminated Valsartan Use: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/incidence-and-prevalence-n-nitrosodimethylamine-ndma-and-n Incidence and Prevalence of N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Contaminated Valsartan Use: A Descriptive Analysis Analyses
Incidence and Prevalence of N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Contaminated Valsartan Use: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/methods/augmenting-date-death-cause-death-ascertainment-sentinel Augmenting Date of Death & Cause of Death Ascertainment in Sentinel Methods, Data, & Tools
Augmenting Date of Death & Cause of Death Ascertainment in Sentinel
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/publications-presentations/impact-nitrosamine-contamination-recalls-angiotensin Impact of Nitrosamine Contamination Recalls on Angiotensin-Receptor-Blocker (ARB) Utilization in the U.S., U.K., Canada, and Denmark Publications and Presentations
Impact of Nitrosamine Contamination Recalls on Angiotensin-Receptor-Blocker (ARB) Utilization in the U.S., U.K., Canada, and Denmark
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/systemic-corticosteroids-covid-19-us-outpatient-settings Systemic Corticosteroids for COVID-19 in U.S. Outpatient Settings Publications and Presentations
Systemic Corticosteroids for COVID-19 in U.S. Outpatient Settings
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/valsartan-losartan-and-irbesartan-use-usa-uk-canada-and Valsartan, Losartan and Irbesartan Use in the USA, UK, Canada and Denmark After the Nitrosamine Recalls: A Descriptive Cohort Study Publications and Presentations
Valsartan, Losartan and Irbesartan Use in the USA, UK, Canada and Denmark After the Nitrosamine Recalls: A Descriptive Cohort Study
Publications and Presentations
https://www.sentinelinitiative.org/methods-data-tools/methods/subset-calibration-methods Subset Calibration Methods Methods, Data, & Tools
Subset Calibration Methods
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/zarxio-filgrastim-sndz Zarxio (Filgrastim-sndz) & Signal Identification Studies
Zarxio (Filgrastim-sndz) & Signal Identification
Studies
https://www.sentinelinitiative.org/news-events/publications-presentations/treatment-and-care-received-children-hospitalized-covid-19 Treatment and Care Received by Children Hospitalized with COVID-19 in a Large Hospital Network in the United States, February 2020 to September 2021 Publications and Presentations
Treatment and Care Received by Children Hospitalized with COVID-19 in a Large Hospital Network in the United States, February 2020 to September 2021
Publications and Presentations
https://www.sentinelinitiative.org/methods-data-tools/methods/utilization-single-and-multiple-inhaler-triple-therapy-among-patients Utilization of Single and Multiple Inhaler Triple Therapy Among Patients with COPD in the Sentinel Distributed Database Methods, Data, & Tools
Utilization of Single and Multiple Inhaler Triple Therapy Among Patients with COPD in the Sentinel Distributed Database
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/publications-presentations/high-dose-dexamethasone-covid-19-not-common-large-us High Dose Dexamethasone for COVID-19 Not Common in a Large US Hospital Network Publications and Presentations
High Dose Dexamethasone for COVID-19 Not Common in a Large US Hospital Network
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/investigating-potential-differences-safety-profiles Investigating Potential Differences in the Safety Profiles of Biosimilars Relative to Originator Products Using a Tree-Based Scan Statistic Publications and Presentations
Investigating Potential Differences in the Safety Profiles of Biosimilars Relative to Originator Products Using a Tree-Based Scan Statistic
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-gimoti-metoclopramide-nasal-spray-0 Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: A Second Descriptive Analysis Analyses
Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: A Second Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/validity-inpatient-electronic-health-record-based-measures Validity of Inpatient Electronic Health Record-Based Measures of Oxygen-Related Therapy in the United States: Lessons Applicable for Studying COVID-19 Endpoints Publications and Presentations
Validity of Inpatient Electronic Health Record-Based Measures of Oxygen-Related Therapy in the United States: Lessons Applicable for Studying COVID-19 Endpoints
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/brexafemme-ibrexafungerp Brexafemme (Ibrexafungerp) & Use in Pregnancy Studies
Brexafemme (Ibrexafungerp) & Use in Pregnancy
Studies
https://www.sentinelinitiative.org/news-events/publications-presentations/high-dimensional-multiple-imputation-hdmi-strategies High-Dimensional Multiple Imputation (hdMI) Strategies for Partially Observed Confounders with Structured and Natural Language Processing-Derived Auxiliary Covariates Publications and Presentations
High-Dimensional Multiple Imputation (hdMI) Strategies for Partially Observed Confounders with Structured and Natural Language Processing-Derived Auxiliary Covariates
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/characterizing-inpatient-electronic-health-records-ehr-large Characterizing Inpatient Electronic Health Records (EHR) from a Large Hospital Network for Use in Neonatal Pharmacoepidemiology Studies in the United States Publications and Presentations
Characterizing Inpatient Electronic Health Records (EHR) from a Large Hospital Network for Use in Neonatal Pharmacoepidemiology Studies in the United States
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-guselkumab-use-signal Outcome Monitoring Following Guselkumab Use: A Signal Identification Analysis Analyses
Outcome Monitoring Following Guselkumab Use: A Signal Identification Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/exposure-valsartan-products-containing-nitrosamine Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark Publications and Presentations
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/applications-real-world-data-rwd-fda-s-sentinel-system Applications of Real-World Data (RWD) in FDA’s Sentinel System Publications and Presentations
Applications of Real-World Data (RWD) in FDA’s Sentinel System
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-guselkumab-use-signal-0 Outcome Monitoring Following Guselkumab Use: A Signal Identification and Self-Controlled Risk Interval Analysis Analyses
Outcome Monitoring Following Guselkumab Use: A Signal Identification and Self-Controlled Risk Interval Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/high-dimensional-multiple-imputation-hdmi-partially-observed High-Dimensional Multiple Imputation (HDMI) for Partially Observed Confounders Including Natural Language Processing-Derived Auxiliary Covariates Publications and Presentations
High-Dimensional Multiple Imputation (HDMI) for Partially Observed Confounders Including Natural Language Processing-Derived Auxiliary Covariates
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/interplay-adverse-events-spontaneous-reporting-and Interplay of Adverse Events, Spontaneous Reporting, and Longitudinal Electronic Health Records for Signal Management Publications and Presentations
Interplay of Adverse Events, Spontaneous Reporting, and Longitudinal Electronic Health Records for Signal Management
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/practical-overview-real-life-challenges-leveraging-ehr-data A Practical Overview of Real-Life Challenges Leveraging EHR Data for the FDA Sentinel System Publications and Presentations
A Practical Overview of Real-Life Challenges Leveraging EHR Data for the FDA Sentinel System
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/cautionary-note-plasmode-simulation-studies-setting-causal A Cautionary Note for Plasmode Simulation Studies in the Setting of Causal Inference Publications and Presentations
A Cautionary Note for Plasmode Simulation Studies in the Setting of Causal Inference
Publications and Presentations
https://www.sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system Sentinel Routine Querying System Methods, Data, & Tools
Sentinel Routine Querying System
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system-reporting-tool Sentinel Routine Querying System Reporting Tool Methods, Data, & Tools
Sentinel Routine Querying System Reporting Tool
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-patterns-inhaler-triple-therapy-patients-chronic Utilization Patterns of Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis Analyses
Utilization Patterns of Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/prescriptions-and-dispensings-central-nervous-system-cns Prescriptions and Dispensings of Central Nervous System (CNS) Stimulants: A Descriptive Analysis Analyses
Prescriptions and Dispensings of Central Nervous System (CNS) Stimulants: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2022-first Duration of Follow Up for New Molecular Entities Approved in 2022: First Descriptive Analysis Analyses
Duration of Follow Up for New Molecular Entities Approved in 2022: First Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/livdelzi-seladelpar Assessment of ARIA Sufficiency: Livdelzi (seladelpar) Sufficiency Assessments
Assessment of ARIA Sufficiency: Livdelzi (seladelpar)
Sufficiency Assessments
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/valsartan-and-non-valsartan-angiotensin-receptor-blocker-1 Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in Canada Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis Analyses
Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in Canada Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/valsartan-and-non-valsartan-angiotensin-receptor-blocker Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in Denmark Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis Analyses
Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in Denmark Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/valsartan-and-non-valsartan-angiotensin-receptor-blocker-0 Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in the United Kingdom Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis Analyses
Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in the United Kingdom Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/valsartan-and-non-valsartan-angiotensin-receptor-blocker-2 Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in the United States Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis Analyses
Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in the United States Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-gimoti-metoclopramide-nasal-spray-1 Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: A Third Descriptive Analysis Analyses
Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: A Third Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/assessing-treatment-effects-observational-data-missing Assessing Treatment Effects in Observational Data with Missing Confounders: A Comparative Study of Practical Doubly-robust and Traditional Missing-data Methods Publications and Presentations
Assessing Treatment Effects in Observational Data with Missing Confounders: A Comparative Study of Practical Doubly-robust and Traditional Missing-data Methods
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-patterns-single-and-multiple-inhaler-triple Utilization Patterns of Single and Multiple Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis Analyses
Utilization Patterns of Single and Multiple Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-confounding-covariates-trinetx-descriptive Characterization of Confounding Covariates in the TriNetX: A Descriptive Analysis Analyses
Characterization of Confounding Covariates in the TriNetX: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2025-ispe-annual-meeting 2025 ISPE Annual Meeting Sentinel Initiative Events 08/22/2025
2025 ISPE Annual Meeting
Sentinel Initiative Events